Trina Solar Ltd. (ADR) (NYSE:TSL) has successfully connected two of its new photovoltaic (PV) power plants to the U.K. grid. Trina is the sole investor and project developer for these power plants, which are located in Cornwall and Dorset. Construction on the plants began in December 2013 and together have a total capacity of 23.77 MW. Trina Solar Limited (ADR) (NYSE:TSL) shares after opening at $13.00 moved to $13.30 on last trade day and at the end of the day closed at $13.13. Company price to sales ratio in past twelve months was calculated as 0.53 and price to cash ratio as 1.92. Trina Solar Limited (ADR) (NYSE:TSL) showed a positive weekly performance of 9.42%.
Freescale Semiconductor, Ltd. (NYSE:FSL) announced financial results for the first quarter ended April 4, 2014. Freescale Semiconductor Ltd (NYSE:FSL) shares advanced 4.35% in last trading session and ended the day on $25.88. FSL return on equity ratio is recorded as 4.60% and its return on assets is -6.30%. Freescale Semiconductor Ltd (NYSE:FSL) yearly performance is 82.25%.
Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary disposable devices used primarily in cardiology, radiology and endoscopy, yesterday announced record sales of $119.2 million for the quarter ended March 31, 2014, an increase of 15% over sales of $103.9 million for the quarter ended March 31, 2013. Merit Medical Systems, Inc. (NASDAQ:MMSI) shares moved up 3.85% in last trading session and was closed at $13.76, while trading in range of $13.04 – $13.90. Merit Medical Systems, Inc. (NASDAQ:MMSI) year to date (YTD) performance is -12.58%.
Healthways logo Healthways Inc. (NASDAQ:HWAY) issued an update on its FY14 earnings guidance on Thursday morning. The company provided EPS guidance of $0.11-0.26 for the period, compared to the Thomson Reuters consensus EPS estimate of $0.16. Healthways, Inc. (NASDAQ:HWAY) weekly performance is -4.74%. On last trading day company shares ended up $16.08. Healthways, Inc. (NASDAQ:HWAY) distance from 50-day simple moving average (SMA50) is 1.99%. Analysts mean target price for the company is $14.00.